recent articles
Exciting news from Visiopharm - their Ki67 diagnostic App has received the CE mark for in-vitro diagnostic use in Europe. The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing